SRDX vs LAKE vs MSA vs NVCR vs HON

For growth investors, Lakeland Industries, Inc.

(LAKE) is the stronger pick with 34. 1% revenue growth year-over-year, versus -4. 9% for Surmodics, Inc. (SRDX). MSA Safety Incorporated (MSA) offers the better valuation at 24. 0x trailing P/E (19. 2x forward), making it the more compelling value choice. Analysts rate Surmodics, Inc. (SRDX) a "Buy" — based on 7 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, MSA Safety Incorporated (MSA) is the cheapest at 24.

0x versus Honeywell International Inc. at 29. 0x. On forward P/E, MSA Safety Incorporated is actually cheaper at 19. 2x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: MSA Safety Incorporated wins at 1. 09x versus Honeywell International Inc. 's 11. 03x — a reasonable growth-adjusted valuation.

Over the past 5 years, MSA Safety Incorporated (MSA) delivered a total return of +7.

9%, compared to -90. 2% for NovoCure Limited (NVCR). Over 10 years, the gap is even starker: MSA returned +290. 0% versus LAKE's +31. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Surmodics, Inc.

(SRDX) is the lower-risk stock at 0. 52β versus NovoCure Limited's 2. 15β — meaning NVCR is approximately 316% more volatile than SRDX relative to the S&P 500. On balance sheet safety, Lakeland Industries, Inc. (LAKE) carries a lower debt/equity ratio of 22% versus 2% for Honeywell International Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Lakeland Industries, Inc.

(LAKE) is pulling ahead at 34. 1% versus -4. 9% for Surmodics, Inc. (SRDX). On earnings-per-share growth, the picture is similar: NovoCure Limited grew EPS 21. 8% year-over-year, compared to -645. 5% for Surmodics, Inc.. Over a 3-year CAGR, LAKE leads at 12. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

MSA Safety Incorporated (MSA) is the more profitable company, earning 14.

9% net margin versus -20. 8% for NovoCure Limited — meaning it keeps 14. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MSA leads at 21. 4% versus -23. 5% for NVCR. At the gross margin level — before operating expenses — NVCR leads at 74. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, MSA Safety Incorporated (MSA) is the more undervalued stock at a PEG of 1. 09x versus Honeywell International Inc. 's 11. 03x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, MSA Safety Incorporated (MSA) trades at 19. 2x forward P/E versus 20. 2x for Honeywell International Inc. — 1. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NVCR: 87. 3% to $33. 50.

In this comparison, HON (2.

2% yield), MSA (1. 2% yield), LAKE (1. 1% yield) pay a dividend. SRDX, NVCR do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Honeywell International Inc.

(HON) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 74), 2. 2% yield, +132. 4% 10Y return). NovoCure Limited (NVCR) carries a higher beta of 2. 15 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (HON: +132. 4%, NVCR: +38. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (SRDX (Healthcare) and LAKE (Consumer Cyclical) and MSA (Industrials) and NVCR (Healthcare) and HON (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: SRDX is a small-cap quality compounder stock; LAKE is a small-cap high-growth stock; MSA is a small-cap quality compounder stock; NVCR is a small-cap quality compounder stock; HON is a mid-cap quality compounder stock. LAKE, MSA, HON pay a dividend while SRDX, NVCR do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.